Company: LNAI
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001731122-25-001544
Chunk: 139

Company: Lunai Bioworks Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 3
Chunk 139
---
. The parties have exchanged paper discovery and noticed depositions. The action has
been held in abeyance while the parties attempt to negotiate a settlement.

Item 1A. Risk Factors.

As a “smaller reporting company”
as defined by Rule 12b-2 of the Securities Exchange Act of 1934, the Company is not required to provide the information required by this
Item.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

On July 7, 2025, the Company issued 5.36 million shares
of common stock, valued at $16.1 million upon the conversion of convertible notes (see Note 6).

Item 3. Defaults Upon Senior Securities. 

None.

Item 4. Mine Safety Disclosures. 

Not applicable.

Item 5. Other Information.

Insider Trading Plans

During the quarter ended September
30, 2025, no director or Section 16 officer adopted, modified, or terminated any “Rule 10b5-1 trading arrangement” or “non-Rule
10b5-1 trading arrangement” (in each case, as defined in Item 408(a) of Regulation S-K).

38

Item 6. Exhibits.

Exhibits required by Item 601 of Regulation S-K:

    Exhibit No.
     
    Description 

     2.1
     
    Agreement and Plan of Merger, dated February 26, 2025, by and among Renovaro, Inc, Renovaro Acquisition Sub and Biosymetrics, Inc. (incorporated by reference to Exhibit 2.1 to the Company’s Form 8-K filed with the SEC on February 28, 2025)

    3.1 
     
    Certificate of Incorporation, as amended (incorporated by reference to Exhibit 3.1 to the Company’s Form 10-Q filed with the SEC on February 14, 2024)

    3.2
     
    Amended and Restated Bylaws (incorporated herein by reference to Exhibit 3.1 to Form 8-K filed with the SEC on May 24, 2024)

    10.1†
     
    Employment Agreement by and between Nathen Fuentes and Renovaro Inc., dated as of January 6, 2025. (incorporated by reference to Exhibit 10.2 to the Company’s Form 10-Q filed with the SEC